Copper(II)-mediated N-terminal modification of proteins with maleimide derivatives

Kengo Hanaya,Kazuaki Taguchi,Yuki Wada,Masaki Kawano,Shuhei Higashibayashi

DOI: https://doi.org/10.26434/chemrxiv-2024-sb5hw

2024-06-20

Abstract:Maleimide derivatives are privileged reagents for the chemical modification of proteins via the Michael addition of cysteine due to their selectivity, reaction rate, and commercial availability. Since accessible free cysteine is rarely found in natural proteins, an alternative target for maleimide derivatives is highly desirable for direct bioconjugation. In this study, we developed a copper(II)-mediated [3+2] cycloaddition reaction with maleimide and 2-pyridinecarboxaldehyde (2-PC) derivatives as an operationally simple and powerful method for the N-terminal modification of peptides and proteins. This method utilizes commercially available maleimides to attach diverse functionalities to various N-terminal amino acids. The combined use of copper(II) ions and heteroaromatic aldehydes is key to the selective formation of azomethine intermediates at the N-terminus in aqueous media under mild conditions, achieving high N-terminal selectivity. We demonstrate the preparation of a ternary protein complex cross-linked at the N-termini and dually modified trastuzumab equipped with monomethyl auristatin E (MMAE), a cytotoxic agent, and a Cy5 fluorophore (MMAE–Cy5–trastuzumab). The MMAE–Cy5–trastuzumab retained human epidermal growth factor receptor 2 (HER2) recognition activity and exerted cytotoxicity against HER2-positive cells. Furthermore, MMAE–Cy5–trastuzumab helped successfully visualize HER2-positive cancer cells in mouse tumors. This straightforward method will enhance the accessibility and utility of protein conjugates with defined structures across a diverse spectrum of researchers.

Chemistry

What problem does this paper attempt to address?

The paper is primarily dedicated to developing a new method for protein modification, specifically through copper(II)-mediated [3+2] cycloaddition reactions to achieve chemical modification of protein N-termini. The research team's goal is to find new targets other than cysteine for direct bioconjugation, particularly using maleimide derivatives as modifiers. The key contributions of the paper are as follows: 1. **Methodological Innovation**: The researchers developed a method based on copper(II)-mediated [3+2] cycloaddition reactions, utilizing maleimide and 2-pyridinecarboxaldehyde (2-PC) derivatives. This method can efficiently and selectively modify the N-termini of peptides and proteins under mild conditions. It overcomes some limitations of traditional methods, such as the need for specific conditions or complex reagent preparation. 2. **Broad Applicability**: This method can effectively modify various types of N-terminal amino acids, including those with charged, bulky, and aromatic side chains. Additionally, it can achieve specific N-terminal modification even in the presence of multiple lysine residues. 3. **Functional Validation**: The researchers demonstrated how to use this technology to prepare ternary protein complexes and dual-modified trastuzumab (MMAE-Cy5-trastuzumab). This dual-modified antibody not only retains its recognition activity for human epidermal growth factor receptor 2 (HER2) but also exhibits cytotoxicity against HER2-positive cells. Furthermore, MMAE-Cy5-trastuzumab successfully labeled HER2-positive cancer cells in mouse tumors and showed good biodistribution characteristics in in vivo experiments. In summary, this work provides a simple and powerful tool for the selective modification of protein N-termini, which will help broaden the accessibility and practicality of bioconjugates. It has significant application prospects in biomedical research and drug development.

Copper(II)-mediated N-terminal modification of proteins with maleimide derivatives

N‐Terminal‐Specific Dual Modification of Peptides through Copper‐Catalyzed [3+2] Cycloaddition

Redox-Based Reagents for Chemoselective Methionine Bioconjugation

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

New Strategies for Cysteine Bioconjugation and Protein Cross-Linking

Facile Cu(ii)-mediated Conjugation of Thioesters and Thioacids to Peptides and Proteins under Mild Conditions.

Copper-Triggered Bioorthogonal Cleavage Reactions for Reversible Protein and Cell Surface Modifications

Hydrolytically Stable Maleimide-End-Functionalized Polymers for Site-Specific Protein Conjugation.

2-cyanopyridine derivatives enable N-terminal cysteine bioconjugation and peptide bond cleavage of glutathione under aqueous and mild conditions

Design and Synthesis of N-Maleimido-Functionalized Hydrophilic Polymers Via Copper-Mediated Living Radical Polymerization: A Suitable Alternative to PEGylation Chemistry

Late-Stage Modification of Peptides with Maleimides through Palladium-Catalyzed β-C(sp 3 )-H Alkylation

Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins.

Sulfoxide-mediated Cys-Trp-selective bioconjugation that enables protein labeling and peptide heterodimerization

Cysteine-specific Protein Multi-Functionalization and Disulfide Bridging Using 3-Bromo-5-methylene Pyrrolones

Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines

Dinitroimidazoles As Bifunctional Bioconjugation Reagents for Protein Functionalization and Peptide Macrocyclization

In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation

On-Demand Thio-Succinimide Hydrolysis for the Assembly of Stable Protein-Protein Conjugates

Late-Stage Peptide Modification and Macrocyclization Enabled by Tertiary Amine Catalyzed Tryptophan Allylation

Enhancement of MALDI-MS spectra of C-terminal peptides by the modification of proteins via an active ester generated in situ from an oxazolone

A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels-Alder Reaction with Maleimide or Proximity-Based Dimerization.